Evidence map›Paper›PMID 41063833›Full record

ReviewFrontiers in cardiovascular medicine2025

Regulation of aquaporin-2 using traditional Chinese medicine in water balance disorders: a literature review.

Yifan Chang, Lu Liu, Xiaodong Xu, Shiqiang Zhang

Abstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yifan ChangThe Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
Lu LiuThe Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
Xiaodong XuHebei Province Key Laboratory of Integrated Traditional and Western Medicine in Neurological Rehabilitation, Hebei Province Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei, China.
Shiqiang ZhangThe Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aquaporin-2 (AQP2) is a critical protein involved in water metabolism. It is primarily located in the renal collecting duct cells' apical plasma membranes and intracellular vesicles and regulates the movement of water into and out of cells. It plays a pivotal role in maintaining fluid balance, and its dysregulation is associated with conditions such as hypertension and heart failure, which contribute to cardiovascular disease progression. AQP2 has garnered significant attention as an emerging therapeutic target. Traditional Chinese medicine (TCM) has demonstrated efficacy in treating water balance disorders, although its underlying mechanisms remain elusive. The discovery of AQP2 and its association with water metabolism provides an opportunity for TCM to explore these mechanisms more intuitively. This review integrates TCM formulas, single herbs, and active constituents, linking them to AQP2 regulation in the kidneys, heart, liver, inner ear, and uterus with an emphasis on the AVP-V2R-AQP2 axis, while distinguishing between short- and long-term regulation and highlighting cardiovascular applications. This review synthesizes the current evidence from experimental and limited clinical studies, highlights the regulatory effects of TCM on AQP2 in various organ systems, and identifies key research gaps to guide future translational and clinical investigations.

Indexed as

Aquaporin-2cardiovascular diseasestraditional Chinese medicinewater balance disordersZhenwu decoction

Identifiers

PMID41063833
PMCPMC12500708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.